Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from a physician concerning a 14 year old female patient with no medical history who on 25-JAN-2012, was vaccinated with a first dose of GARDASIL, (lot number 668261/1397AA), (dose, route not reported) for prevention of HPV. Concomitant therapy included MENACTRA. On 26-JAN-2012, one day after receiving the first shot of GARDASIL, the patient experienced swelling at the injection site and numbness down the left arm and also on the lower left extremity. The patient also had swelling and purpling of the limbs and digits. The patient also was extremely fatigued and had uncontrollable bowel movements. On an unknown date, the patient was taken to the ER (hospital unknown) and was put on steroids and BENADRYL. Therapy with GARDASIL was not discontinued. At the time of the report the patient''s outcome was recovering. The patient sought medical attention. Swelling at the injection site and numbness down the left arm and also on the lower left extremity, swelling and purpling of the limbs and digits, extremely fatigued and uncontrollable bowel movements were considered to be disabling. Additional information has been requested.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166